Isotretinoin Capsule, Liquid Filled
Product Images NDC 68308-573

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 68308-573). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isotretinoin 01)

Chemical structure diagram of isotretinoin, showing its molecular framework with multiple double bonds and a carboxylic acid group (COOH) at one end.*

FDA Label Image

Figure 1 (Isotretinoin 02)

A line graph depicting the mean lesion count over time from Baseline through Week 20 during analysis visits for Isotretinoin Capsules and Isotretinoin. The y-axis shows mean lesion count decreasing from about 20 to below 5, while the x-axis marks time points at Baseline, Week 4, 8, 12, 16, and 20. Two lines represent Isotretinoin Capsules and Isotretinoin with similar downward trends.*

FDA Label Image

Principal Display Panel (10 mg Capsule Blister Pack Box)

Packaging label for Isotretinoin Capsules, USP 10 mg by Mayne Pharma. The label indicates each capsule contains 10 mg of Isotretinoin. The package contains 30 capsules (3 x 10 Prescription Packs). Warning text highlights the risk of birth defects and instructs pharmacists to dispense with an enclosed Medication Guide. Storage instructions include protecting the product from light and storing at controlled room temperature. The product is distributed by Mayne Pharma in Greenville, NC.*

FDA Label Image

Principal Display Panel (20 mg Capsule Blister Pack Box)

Packaging label for Isotretinoin Capsules, USP 20 mg, a liquid-filled oral capsule by Mayne Pharma. The label states each capsule contains 20 mg of isotretinoin and the package contains 30 capsules in 3x10 prescription packs. It includes prominent warnings about birth defects and pregnancy prevention, pharmacist dispensing instructions, storage conditions, and a barcode.*

FDA Label Image

Principal Display Panel (30 mg Capsule Blister Pack Box)

Isotretinoin Capsules, USP 30 mg carton for oral use, showing multiple panels with warnings about birth defects and pregnancy prevention. The label indicates a package of 30 capsules (3 x 10 prescription packs) by Mayne Pharma, with storage instructions and authorization details for dispensing through the iPLEDGE Program. Prominent cautionary statements instruct pharmacists to dispense with an enclosed medication guide and highlight the teratogenic risk.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.